Hearing Loss Trial, Recruiting NCT04240561 Sponsor: Northwestern University Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT04240561
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose first language is English
  • People with normal vision, or vision that is corrected to normal with glasses or contact lenses (20/40 binocular vision or better, as measured by a standard eye chart)
  • People with a specific type and degree of hearing loss — sensorineural hearing loss — measured at a moderate level across a range of sound frequencies (confirm with trial site for exact hearing test results required)
  • People who have a Clinical Dementia Rating (CDR) score of 0.5 or 1, which indicates slight or mild difficulties with memory, thinking, and daily activities
  • People who have been diagnosed with Alzheimer's-type dementia or a mild memory-related cognitive impairment, with a thinking and memory test score (MoCA) of 18 or above
  • People who are living in their own home
  • People who have completed at least Year 10 of education
  • People who are able to give their own informed consent to take part, as assessed through a consent evaluation

Who may not be able to join:

  • People with serious, unstable, or worsening health conditions that the research team considers would put them at unacceptable risk by taking part
  • People who have ongoing communication difficulties caused by another neurological condition (such as stroke or brain tumour), a neurodevelopmental condition (such as Down syndrome), or head or neck cancer
  • People with a history of a major psychiatric condition, such as schizophrenia or significant untreated depression
  • People who are already taking part in another research study focused on hearing, language, or communication
  • People whose hearing loss is caused by a blockage or structural problem in the ear (conductive hearing loss), was present from birth, or fluctuates over time
  • People who currently wear hearing aids regularly, defined as wearing them at least 4 hours a day on most days over the past year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pam Souza, PhD, Northwestern University

Phone: 847-467-0897

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2021
Est. completion
31 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change In Speech Intelligibility (%Correct); Change in Conversation Analysis of Communication Breakdown

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov